Year |
Citation |
Score |
2022 |
Arami H, Kananian S, Khalifehzadeh L, Patel CB, Chang E, Tanabe Y, Zeng Y, Madsen SJ, Mandella MJ, Natarajan A, Peterson EE, Sinclair R, Poon ASY, Gambhir SS. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nature Nanotechnology. PMID 35995855 DOI: 10.1038/s41565-022-01189-y |
0.355 |
|
2021 |
Aguilar AA, Ho MC, Chang E, Carlson KW, Natarajan A, Marciano T, Bomzon Z, Patel CB. Permeabilizing Cell Membranes with Electric Fields. Cancers. 13. PMID 34068775 DOI: 10.3390/cancers13092283 |
0.412 |
|
2020 |
Chang E, Patel C, Young C, Flores T, Zeng Y, Joubert L, Arami H, Natarajan A, Sinclair R, Gambhir S. CSIG-14. COMBINING THE GLIOBLASTOMA CELL MEMBRANE-PERMEABILIZING EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) WITH WITHAFERIN A (AND OTHER) CHEMOTHERAPY Neuro-Oncology. 22: ii30-ii30. DOI: 10.1093/neuonc/noaa215.126 |
0.324 |
|
2019 |
Chang E, Patel C, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Abstract 250: Tumor treating fields increases membrane permeability in glioblastoma cells Cancer Research. 79: 250-250. DOI: 10.1158/1538-7445.Am2019-250 |
0.355 |
|
2019 |
Chang E, Patel C, Beinat C, Young C, Flores T, Zeng Y, Joubert L, Arami H, Natarajan A, Sinclair R, Gambhir S. EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS Neuro-Oncology. 21: vi93-vi93. DOI: 10.1093/Neuonc/Noz175.384 |
0.326 |
|
2018 |
Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell Death Discovery. 4: 113. PMID 30534421 DOI: 10.1038/S41420-018-0130-X |
0.438 |
|
2018 |
Natarajan A, Patel CB, Ramakrishnan S, Panesar PS, Long SR, Gambhir SS. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1 : Validation in Mouse Models and Human Cancer Tissues. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30373750 DOI: 10.1158/1078-0432.Ccr-18-1871 |
0.407 |
|
2018 |
Natarajan A, Patel CB, Habte F, Gambhir SS. Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression. Scientific Reports. 8: 633. PMID 29330552 DOI: 10.1038/S41598-017-19123-X |
0.409 |
|
2005 |
DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy Clinical Cancer Research. 11: 7087s-7092s. PMID 16203807 DOI: 10.1158/1078-0432.CCR-1004-0022 |
0.311 |
|
Show low-probability matches. |